The use of Low Molecular Weight Heparin to Predict Clinical Outcome in Patients with Unstable Angina That Had Undergone Percutaneous Coronary Intervention

BACKGROUND: Antithrombotic therapy with heparin reduces the rate of ischemic events in patients with acute coronary syndrome. Low-molecular-weight heparin, given subcutaneously twice daily, has a more predictable anticoagulant effect than standard unfractionated heparin. Moreover, it is easier to ad...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Korean J Intern Med
Autors principals: Hong, Young Joon, Jeong, Myung Ho, Lee, Seung Hyun, Park, Ok Young, Kim, Ju Han, Kim, Weon, Rhew, Jay Young, Ahn, Young Keun, Cho, Jeong Gwan, Park, Jong Chun, Suh, Soon Pal, Ahn, Byoung Hee, Kim, Sang Hyung, Kang, Jung Chaee
Format: Artigo
Idioma:Inglês
Publicat: Korean Association of Internal Medicine 2003
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4531631/
https://ncbi.nlm.nih.gov/pubmed/14619386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2003.18.3.167
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars